These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23154288)

  • 1. Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics.
    Kostakioti M; Hultgren SJ; Hadjifrangiskou M
    Virulence; 2012 Nov; 3(7):592-4. PubMed ID: 23154288
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Bessaiah H; Pokharel P; Habouria H; Houle S; Dozois CM
    Front Cell Infect Microbiol; 2019; 9():312. PubMed ID: 31555608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Regulation of the Diguanylate Cyclase YaiC Reduces Production of Type 1 Fimbriae in a Pst Mutant of Uropathogenic Escherichia coli CFT073.
    Crépin S; Porcheron G; Houle S; Harel J; Dozois CM
    J Bacteriol; 2017 Dec; 199(24):. PubMed ID: 28924030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.
    Floyd KA; Mitchell CA; Eberly AR; Colling SJ; Zhang EW; DePas W; Chapman MR; Conover M; Rogers BR; Hultgren SJ; Hadjifrangiskou M
    J Bacteriol; 2016 Oct; 198(19):2662-72. PubMed ID: 27161114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.
    Kostakioti M; Hadjifrangiskou M; Cusumano CK; Hannan TJ; Janetka JW; Hultgren SJ
    Infect Immun; 2012 Aug; 80(8):2826-34. PubMed ID: 22665375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.
    Crépin S; Houle S; Charbonneau MÈ; Mourez M; Harel J; Dozois CM
    Infect Immun; 2012 Aug; 80(8):2802-15. PubMed ID: 22665376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of not sensing phosphate: downregulation of type 1 fimbriae through activation of the Pho regulon reduces E. coli urinary tract virulence.
    Crépin S; Porcheron G; Harel J; Dozois CM
    Virulence; 2012 Nov; 3(7):596-8. PubMed ID: 23154290
    [No Abstract]   [Full Text] [Related]  

  • 8. Impairment of the biomechanical compliance of P pili: a novel means of inhibiting uropathogenic bacterial infections?
    Klinth JE; Pinkner JS; Hultgren SJ; Almqvist F; Uhlin BE; Axner O
    Eur Biophys J; 2012 Mar; 41(3):285-95. PubMed ID: 22237603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs).
    Behzadi P
    Folia Microbiol (Praha); 2020 Feb; 65(1):45-65. PubMed ID: 31165977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection.
    Snyder JA; Lloyd AL; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2006 Feb; 74(2):1387-93. PubMed ID: 16428790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.
    Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL
    Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic roles of uvrY on biofilm formation, motility and virulence in uropathogenic Escherichia coli CFT073.
    Mitra A; Palaniyandi S; Herren CD; Zhu X; Mukhopadhyay S
    PLoS One; 2013; 8(2):e55492. PubMed ID: 23383333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective anti-adhesives of uropathogenic Escherichia coli.
    Ribić R; Meštrović T; Neuberg M; Kozina G
    Acta Pharm; 2018 Mar; 68(1):1-18. PubMed ID: 29453908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative proteomics of uropathogenic Escherichia coli during growth in human urine identify UCA-like (UCL) fimbriae as an adherence factor involved in biofilm formation and binding to uroepithelial cells.
    Wurpel DJ; Totsika M; Allsopp LP; Webb RI; Moriel DG; Schembri MA
    J Proteomics; 2016 Jan; 131():177-189. PubMed ID: 26546558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processive dynamics of the usher assembly platform during uropathogenic Escherichia coli P pilus biogenesis.
    Du M; Yuan Z; Werneburg GT; Henderson NS; Chauhan H; Kovach A; Zhao G; Johl J; Li H; Thanassi DG
    Nat Commun; 2021 Sep; 12(1):5207. PubMed ID: 34471127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.
    Vigil PD; Wiles TJ; Engstrom MD; Prasov L; Mulvey MA; Mobley HL
    Infect Immun; 2012 Feb; 80(2):493-505. PubMed ID: 22083710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fimbriae as virulence factors of uropathogenic strains of Escherichia coli].
    Rytlewska M; Liberek A; Sikorska-Wisniewska G; Bako W
    Med Wieku Rozwoj; 2005; 9(4):743-52. PubMed ID: 16733282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sRNA-Mediated Regulation of P-Fimbriae Phase Variation in Uropathogenic Escherichia coli.
    Khandige S; Kronborg T; Uhlin BE; Møller-Jensen J
    PLoS Pathog; 2015 Aug; 11(8):e1005109. PubMed ID: 26291711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.